Bicycle Therapeutics Statistics
Total Valuation
BCYC has a market cap or net worth of $254.77 million. The enterprise value is -$240.62 million.
| Market Cap | 254.77M |
| Enterprise Value | -240.62M |
Important Dates
The next estimated earnings date is Thursday, October 29, 2026, before market open.
| Earnings Date | Oct 29, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
BCYC has 69.99 million shares outstanding. The number of shares has increased by 0.52% in one year.
| Current Share Class | n/a |
| Shares Outstanding | 69.99M |
| Shares Change (YoY) | +0.52% |
| Shares Change (QoQ) | +0.17% |
| Owned by Insiders (%) | 1.28% |
| Owned by Institutions (%) | 39.59% |
| Float | n/a |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 4.16 |
| Forward PS | 15.90 |
| PB Ratio | 0.50 |
| P/TBV Ratio | 0.50 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 12.08, with a Debt / Equity ratio of 0.03.
| Current Ratio | 12.08 |
| Quick Ratio | 11.70 |
| Debt / Equity | 0.03 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -1,067.88 |
Financial Efficiency
Return on equity (ROE) is -32.30% and return on invested capital (ROIC) is -21.45%.
| Return on Equity (ROE) | -32.30% |
| Return on Assets (ROA) | -17.91% |
| Return on Invested Capital (ROIC) | -21.45% |
| Return on Capital Employed (ROCE) | -36.87% |
| Weighted Average Cost of Capital (WACC) | 12.09% |
| Revenue Per Employee | $212,517 |
| Profits Per Employee | -$661,153 |
| Employee Count | 288 |
| Asset Turnover | 0.09 |
| Inventory Turnover | n/a |
Taxes
In the past 12 months, BCYC has paid $1.73 million in taxes.
| Income Tax | 1.73M |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -46.94% in the last 52 weeks. The beta is 1.54, so BCYC's price volatility has been higher than the market average.
| Beta (5Y) | 1.54 |
| 52-Week Price Change | -46.94% |
| 50-Day Moving Average | 4.10 |
| 200-Day Moving Average | 5.09 |
| Relative Strength Index (RSI) | 32.73 |
| Average Volume (20 Days) | 392,552 |
Short Selling Information
The latest short interest is 3.28 million, so 8.40% of the outstanding shares have been sold short.
| Short Interest | 3.28M |
| Short Previous Month | 3.22M |
| Short % of Shares Out | 8.40% |
| Short % of Float | n/a |
| Short Ratio (days to cover) | 11.64 |
Income Statement
In the last 12 months, BCYC had revenue of $61.21 million and -$190.41 million in losses. Loss per share was -$2.74.
| Revenue | 61.21M |
| Gross Profit | -127.85M |
| Operating Income | -206.10M |
| Pretax Income | -188.68M |
| Net Income | -190.41M |
| EBITDA | -200.81M |
| EBIT | -206.10M |
| Loss Per Share | -$2.74 |
Balance Sheet
The company has $510.05 million in cash and $14.66 million in debt, with a net cash position of $495.39 million or $7.08 per share.
| Cash & Cash Equivalents | 510.05M |
| Total Debt | 14.66M |
| Net Cash | 495.39M |
| Net Cash Per Share | $7.08 |
| Equity (Book Value) | 510.26M |
| Book Value Per Share | 7.31 |
| Working Capital | 527.60M |
Cash Flow
In the last 12 months, operating cash flow was -$206.05 million and capital expenditures -$2.23 million, giving a free cash flow of -$208.28 million.
| Operating Cash Flow | -206.05M |
| Capital Expenditures | -2.23M |
| Depreciation & Amortization | 5.29M |
| Net Borrowing | -196,000 |
| Free Cash Flow | -208.28M |
| FCF Per Share | -$2.98 |
Margins
| Gross Margin | -208.89% |
| Operating Margin | -336.74% |
| Pretax Margin | -308.28% |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
BCYC does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -0.52% |
| Shareholder Yield | -0.52% |
| Earnings Yield | -74.74% |
| FCF Yield | -81.75% |
Analyst Forecast
The average price target for BCYC is $9.50, which is 160.99% higher than the current price. The consensus rating is "Buy".
| Price Target | $9.50 |
| Price Target Difference | 160.99% |
| Analyst Consensus | Buy |
| Analyst Count | 9 |
| Revenue Growth Forecast (3Y) | -40.08% |
| EPS Growth Forecast (3Y) | n/a |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
BCYC has an Altman Z-Score of 0.43 and a Piotroski F-Score of 3. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | 0.43 |
| Piotroski F-Score | 3 |